Brian Goff is expected to replace Carsten Thiel in June. The drugmaker said Tuesday that Thiel along with several other execs would be leaving the firm.
Holly Henry, previously chief medical officer at FCB Health, will oversee medical strategy in the newly created role.
Deborah Furey will lead the agency’s pilot of a new personalized marketing offering.
Millian, a former Sanofi and Merck executive, on marketing new therapies in the MS market.
The chief planning officer of North America talks about strategy and how to tell an engaging health story.
Please login or register first to view this content.